Current malaria management: guideline 2009.

Area of Science:

• Global Health
• Infectious Diseases
• Tropical Medicine

Background:

• Malaria poses a significant health burden globally, particularly in Indonesia, characterized by high morbidity and mortality rates.
• Increasing anti-malarial resistance, including chloroquine-resistant Plasmodium vivax and Plasmodium falciparum, is a major concern in Indonesia.
• Challenges in malaria control include inadequate diagnostic facilities and diverse treatment options, contributing to treatment failures.

Purpose of the Study:

• To outline the national strategy for malaria elimination in Indonesia, focusing on improved diagnosis and treatment protocols.
• To highlight the importance of Artemisinin Combination Therapy (ACT) as the first-line treatment to combat anti-malarial resistance.
• To detail the principles of severe malaria management, emphasizing supportive care, causal treatment, and complication management.

Main Methods:

• Adoption of blood smear confirmation as the gold standard for malaria diagnosis.
• Implementation of Artemisinin Combination Therapy (ACT) as the primary treatment regimen.
• Guidelines for severe malaria management, including parenteral artemisinin administration and transition to oral therapy.

Main Results:

• The Ministry of Health, Republic of Indonesia, launched the Malaria Elimination Program in 2009.
• Emphasis on accurate diagnosis through blood smear confirmation.
• Introduction of ACT to prevent and manage anti-malarial resistance.

Conclusions:

• The Malaria Elimination Program 2009 aims to reduce malaria burden in Indonesia through standardized diagnosis and treatment.
• Artemisinin-based Combination Therapy (ACT) is crucial for effective malaria treatment and resistance prevention.
• Comprehensive management of severe malaria is vital to minimize mortality and improve patient outcomes.